These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 22014934)

  • 1. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
    Fan W; Yan W; Xu Z; Ni H
    Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate.
    Koukaras EN; Papadimitriou SA; Bikiaris DN; Froudakis GE
    Mol Pharm; 2012 Oct; 9(10):2856-62. PubMed ID: 22845012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances.
    Desai KG
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):107-58. PubMed ID: 27651100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.
    Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H; Alpar HO
    J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of chitosan-stabilized gold nanoparticles in the absence/presence of tripolyphosphate.
    Huang H; Yang X
    Biomacromolecules; 2004; 5(6):2340-6. PubMed ID: 15530050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
    Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
    Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
    Csaba N; Köping-Höggård M; Alonso MJ
    Int J Pharm; 2009 Dec; 382(1-2):205-14. PubMed ID: 19660537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavitation effect on chitosan nanoparticle size: a possible approach to protect drugs from ultrasonic stress.
    Floris A; Meloni MC; Lai F; Marongiu F; Maccioni AM; Sinico C
    Carbohydr Polym; 2013 Apr; 94(1):619-25. PubMed ID: 23544582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monovalent salt enhances colloidal stability during the formation of chitosan/tripolyphosphate microgels.
    Huang Y; Lapitsky Y
    Langmuir; 2011 Sep; 27(17):10392-9. PubMed ID: 21749043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H; Oh M; Allen C; Kumacheva E
    Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Carbohydr Polym; 2013 May; 94(2):940-5. PubMed ID: 23544653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiomer nanoparticles: stabilization via covalent cross-linking.
    Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
    Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
    Raja MA; Katas H; Jing Wen T
    PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems.
    Papadimitriou SA; Achilias DS; Bikiaris DN
    Int J Pharm; 2012 Jul; 430(1-2):318-27. PubMed ID: 22521711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.